Pediatric anesthesia & critical care

Total Intravenous Versus Volatile Anesthesia in Pediatric Cardiac Surgery: Inflammatory Response and Early Recovery Profiles

J Cardiothorac Vasc AnesthPublished Randomised controlled trial

Authors' conclusion

Interleukin-6 responses, the primary outcome, were comparable between groups. However, TIVA was associated with higher early MMSE scores and shorter ventilation duration, suggesting potential neuroprotective benefits.

Study context

Population
Children aged 1 to 12 years undergoing elective open heart surgery requiring CPB, tertiary pediatric cardiac surgery centre
Participants
50 children
Comparison
Propofol-based total intravenous anesthesia (TIVA) vs sevoflurane-based volatile anaesthesia
Primary endpoint
Interleukin-6 concentration
Follow-up
Baseline, 6 hours, and 24 hours postoperatively
Methodological detailsprospective, single-centre
  • Prospective
  • Single-centre

Primary result

As reported in the abstract

  • Interleukin-6 increased significantly in both groups; no difference between groups at any time point

Secondary outcomes

Duration of mechanical ventilation · shorter in the TIVA group

P = 0.045

OutcomeTIVAVolatileP value
Pediatric-adapted MMSE score (children aged 4 years and older) · 24 hours post extubationSignificantly higher in the TIVA groupmean 23.7 ± 2.1mean 15.1 ± 3.0P < 0.01
Pediatric-adapted MMSE score (children aged 4 years and older) · 48 hours27.2 ± 1.423.6 ± 2.8P < 0.05
  • Pediatric-adapted Mini-Mental State Examination (MMSE) score (children aged 4 years and older): assessed in 34 children
  • Pediatric-adapted MMSE score (children aged 4 years and older): assessed in 34 children

Original publication

Total Intravenous Versus Volatile Anesthesia in Pediatric Cardiac Surgery: Inflammatory Response and Early Recovery Profiles. J Cardiothorac Vasc Anesth. Published 9 October 2025. doi:10.1053/j.jvca.2025.09.238

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.